Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Genmab reported DKK286M in Pre-Tax Profit for its fiscal quarter ending in March of 2023.

Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US USD -81018000 117.54M
Amarin AMRN:US USD -14496000 7.72M
AstraZeneca AZN:LN USD 3.71B 1.41B
Bluebird Bio BLUE:US USD 21.24M 11.1M
Demant A/s WDH:DC DKK 1.43B 59M
Exelixis EXEL:US USD 48.28M 79.7M
Fresenius Medical Care FME:GR EUR 246M 144.62M
Genmab GEN:DC DKK 286M 376M
GN Store Nord GN:DC DKK -56000000 410M
Hikma Pharmaceutical HIK:LN USD 269M 18M
Immunogen IMGN:US USD -41014000 16.78M
Insmed INSM:US USD -159281000 717K
Lonza Group LONN:SW CHF 683M 36M
Roche Holding ROG:VX CHF 8.85B 3.26B
Seattle Genetics SGEN:US USD -170113000 26.28M